Renal impairment GLP-1 RAs are generally safe in patients with CKD and have demonstrated nephroprotective effects in the FLOW trial, where semaglutide significantly reduced the composite renal endpoint (hospitalization for acute kidney injury, sustained 50% decline in estimated glomerular filtration rate (eGFR), end-stage kidney disease, or renal death) in patients with type 2 diabetes and CKD [15]
After finishing, hold the needle in place for 10 seconds before removing it to prevent leakage of the injected liquid
Buzz has been building around the experimental drug retatrutide (reta) after data from late-stage clinical trials suggest it could be the most powerful obesity drug yet
Ozempic is used for type 2 diabetes
Retatrutide remains investigational and is not approved by the FDA for human use
It acts on the bodies melanocortin receptors, which is the 'really interesting bit', according to the Australia-based medic - as these aren't just in your skin